Dr. Allen Traficante, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Joanna Way, Chatham, NJ 07928 Phone: 973-635-6547 Fax: 973-635-5826 |
John Franzese, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 396 Main St, Chatham, NJ 07928 Phone: 973-701-8277 Fax: 973-701-9546 |
Mr. Robert M. Freda, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 96 Meyersville Road, Chatham, NJ 07928 Phone: 973-635-2289 Fax: 973-635-0834 |
Dr. Neal Collins, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 19 N Hillside Ave, Chatham, NJ 07928 Phone: 973-665-1665 |
Dr. Jillian Ruth Pincus, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1 Plymouth Rd, Chatham, NJ 07928 Phone: 973-635-6055 |
Dr. Wayne M Lajewski, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 159 Main St Ste 1b, Chatham, NJ 07928 Phone: 973-307-0253 Fax: 888-857-0047 |
Dr. Samit Hirawat, M.D. Internal Medicine - Medical Oncology Medicare: Not Enrolled in Medicare Practice Location: 5 Buxton Rd, Chatham, NJ 07928 Phone: 973-701-0808 |
Dr. James M Depasquale, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Main St, Blume, Goldfaden, Chatham, NJ 07928 Phone: 973-635-5400 |
Dr. Rajiv Patni, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 66 Lisa Dr, Chatham, NJ 07928 Phone: 973-701-1084 |
News Archive
As a wide variety of nanoparticles continue to demonstrate their ability to improve the delivery of imaging agents and drugs to tumors, nanoparticle researchers have turned their attention to the challenge of systematically determining how a given nanoparticle's physical and chemical characteristics affect its ability to target tumors. Such data could provide drug developers with guidelines to help them select the most effective type of nanoparticle for a given therapeutic or imaging application.
The Physicians Foundation, a nonprofit organization that seeks to advance the work of practicing physicians and improve the quality of healthcare for all Americans, has retained CooperKatz & Company, as its public relations agency.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.
The Wellcome Trust, one of the world's largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world's most neglected tropical diseases.
› Verified 6 days ago